6/24/2020CDE Solicits Comments on the Technical Guidelines for Clinical Trial E...

6/24/2020CDE Issues Clinical Research Design Guidelines for Liraglutide Injecti...

6/24/2020EU Chamber of Commerce Publishes Its China Business Confidence Survey ...

6/24/2020Novartis Launches Glaucoma Drug Simbrinza in China

6/23/2020WuXi NextCODE Transitions into Genuity Science After Cutting Off Chine...

6/23/2020Clover Biopharma Launches Sixth Chinese COVID-19 Vaccine Trial

6/23/2020In Depth: Decoding China's First Civil Code

6/23/2020Punitive Damages in China's New Civil Code

6/23/2020SinocellTech Launches IPO on STAR Market

6/23/2020Bio-Thera's Avastin Biosimilar Application Accepted by NMPA

6/22/2020Sanofi Pledge Commitment to China with Investment in Global VC

6/22/2020Aurobindo Moves to Expand in China

6/22/2020Agenus and Betta Pharma Enter Into a License Deal for Balstilimab and ...

6/22/2020IMBCAMS Begins Phase II Trial of Its Covid-19 Vaccine

6/22/2020Merck's Keytruda Gets Chinese Approval for Additional Indication for E...

6/22/2020Ascentage and AZ's Acerta Form Partnership to Evaluate the Combo of Bc...

6/22/2020Roche's HBV Combo Treatment Granted Tacit Clinical Trial Approval in C...

6/22/2020Sanofi Granted Chinese Approval of Dupixent (dupilumab)

6/19/2020Recent Executive Movements

6/19/2020Ascentage Submits Its First NDA to NMPA for Third-Gen BCR-ABL Inhibito...

6/19/2020NMPA Approves Clinical Trial of IMCAS's mAb Against Covid-19

6/18/2020Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin's Pha...

6/18/2020Innovent Announces Chinese Approval for BYVASDA (Bevacizumab Biosimila...

6/18/2020Fosun-backed CQP Unit to Acquire Tasly Pharma for $210M

6/18/2020EMA Accepts BeiGene's Marketing Authorization Application for BRUKINSA...

6/18/2020Shanghai Fudan-Zhangjiang Bio-Pharma's IPO Debut on SSE STAR Market

6/18/2020Central Government Issues Notice on Urban and Rural Resident BMI Tasks...

6/18/2020NHSA Issues the Subgrouping Plan of BMI Diagnosis Related Groups (Vers...

6/18/2020Chi-Med's Colorectal Cancer Drug Gets Fast Track Designation in US

6/18/2020McKinsey: Running on the China Bridge to Innovation

Page:232/774 Total number of articles:23207: [First][<<] [230] [231] [232] [233] [234] [>>] [End]